Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AMLCourtney D. DiNardo, Hagop M. Kantarjian, Ronan Swords et al.|New England Journal of Medicine|2018Cited by 1.4k
A phase 2 study of vorinostat in acute myeloid leukemiaÉlise Schaefer, S. D. Gore, Arturo Loaiza‐Bonilla et al.|Haematologica|2009Cited by 119
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosisTania Jain, Jeanne Palmer, Katie L. Kunze et al.|Bone Marrow Transplantation|2018Cited by 46